Skip to Content
Redy Biosciences
Home
Services
Plasmid DNA Preparation
CAR-T/CAR-NK Development
In Vivo CAR-T Development
Protein Expression Services
Cell Line Engineering
Genome Editing Verification
Products
Primary Cells
Cell Lines
Biosimilar Antibodies
About
Contact
Login Account
0
0
Redy Biosciences
Home
Services
Plasmid DNA Preparation
CAR-T/CAR-NK Development
In Vivo CAR-T Development
Protein Expression Services
Cell Line Engineering
Genome Editing Verification
Products
Primary Cells
Cell Lines
Biosimilar Antibodies
About
Contact
Login Account
0
0
Home
Folder: Services
Back
Plasmid DNA Preparation
CAR-T/CAR-NK Development
In Vivo CAR-T Development
Protein Expression Services
Cell Line Engineering
Genome Editing Verification
Folder: Products
Back
Primary Cells
Cell Lines
Biosimilar Antibodies
About
Contact
Login Account

RPMI 8226/GFP-Firefly Luciferase Cell Line

$1,799.00

Description: RPMI 8226 is a human multiple myeloma cell line originally derived from a patient with plasmacytoma. These cells constitutively express BCMA and CD38, making them a physiologically relevant model for evaluating cancer immunotherapies, including Chimeric Antigen Receptor (CAR) T cells. The RPMI 8226/GFP-firefly luciferase variant stably expresses both GFP and firefly luciferase, enabling use in in vitro cytotoxicity assays and in vivo studies.

Quantity: One vial of frozen cells (2×106 per vial)

Stability: Stable in culture over a minimum of 10 passages

Application: Drug screening, biological assays and in vivo study

Freezing Medium: 7% RPMI 1640 +20% FBS+10% DMSO

Propagation Medium: RPMI1640+10%FBS

Morphology: Lymphoblast

Subculture: Start cultures 5.0 X 105 cells/mL maintain between 1.0 X 105 and 2.0 X 106 cells/mL.

Incubation: 37 °C with 5% CO2

Storage: Liquid nitrogen immediately upon receiving

Doubling Time: Approximately 26 hours

Mycoplasma Status: Negative

Caution: This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information.

Cell Lines RPMI 8226/GFP-Firefly Luciferase Cell Line
Quantity:
Add To Cart

Description: RPMI 8226 is a human multiple myeloma cell line originally derived from a patient with plasmacytoma. These cells constitutively express BCMA and CD38, making them a physiologically relevant model for evaluating cancer immunotherapies, including Chimeric Antigen Receptor (CAR) T cells. The RPMI 8226/GFP-firefly luciferase variant stably expresses both GFP and firefly luciferase, enabling use in in vitro cytotoxicity assays and in vivo studies.

Quantity: One vial of frozen cells (2×106 per vial)

Stability: Stable in culture over a minimum of 10 passages

Application: Drug screening, biological assays and in vivo study

Freezing Medium: 7% RPMI 1640 +20% FBS+10% DMSO

Propagation Medium: RPMI1640+10%FBS

Morphology: Lymphoblast

Subculture: Start cultures 5.0 X 105 cells/mL maintain between 1.0 X 105 and 2.0 X 106 cells/mL.

Incubation: 37 °C with 5% CO2

Storage: Liquid nitrogen immediately upon receiving

Doubling Time: Approximately 26 hours

Mycoplasma Status: Negative

Caution: This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information.

Cell Lines RPMI 8226/GFP-Firefly Luciferase Cell Line

Redy Biosciences/RedyBio is a contract research organization (CRO) established by a team of seasons scientists, quality professionals, and biotechnology service experts.

Sign up with your email address to receive news and updates.

Your email is successfully captured. Thank you!

Links

Home

Services

Products

Contact us

About

Contact Us

Email:
info@redybio.com

Phone:
(858) 876-8688

Location:
6331 Nancy Ridge Dr. Suite A
San Diego, CA 92121